Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

253 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
International Bladder Cancer Group Consensus Statement on Clinical Trial Design for Patients with Bacillus Calmette-Guérin-exposed High-risk Non-muscle-invasive Bladder Cancer.
Roumiguié M, Kamat AM, Bivalacqua TJ, Lerner SP, Kassouf W, Böhle A, Brausi M, Buckley R, Persad R, Colombel M, Lamm D, Palou-Redorta J, Soloway M, Brothers K, Steinberg G, Lotan Y, Sylvester R, Alfred Witjes J, Black PC. Roumiguié M, et al. Eur Urol. 2022 Jul;82(1):34-46. doi: 10.1016/j.eururo.2021.12.005. Epub 2021 Dec 23. Eur Urol. 2022. PMID: 34955291 Review.
PD-L1 expression and pattern of immune cells in pre-treatment specimens are associated with disease-free survival for HR-NMIBC undergoing BCG treatment.
Roumiguié M, Compérat E, Chaltiel L, Nouhaud FX, Verhoest G, Masson-Lecomte A, Colin P, Audenet F, Houédé N, Larré S, Xylinas E, Brunelle S, Piana-Thomassin J, Cotte J, Pignot G, Neuzillet Y, Rouprêt M. Roumiguié M, et al. World J Urol. 2021 Nov;39(11):4055-4065. doi: 10.1007/s00345-020-03329-2. Epub 2020 Jul 14. World J Urol. 2021. PMID: 32666225
Comparison of the Comprehensive Complication Index and Clavien-Dindo systems in predicting perioperative outcomes following radical nephroureterectomy.
Geiger S, Kocher N, Illinsky D, Xylinas E, Chang P, Dewey L, Wagner AA, Petros F, Matin SF, Tobert C, Tracy C, Patard PM, Roumiguie M, Monteiro LL, Kassouf W, Raman JD. Geiger S, et al. Among authors: roumiguie m. Transl Androl Urol. 2020 Aug;9(4):1780-1785. doi: 10.21037/tau.2020.01.16. Transl Androl Urol. 2020. PMID: 32944540 Free PMC article.
Comparison of the prognosis of primary vs. progressive muscle invasive bladder cancer after radical cystectomy: Results from a large multicenter study.
Nouhaud FX, Chakroun M, Lenormand C, Ouzaid I, Peyronnet B, Gryn A, Prudhomme T, Grafeille V, Soulié M, Roumiguié M, Verhoest G, Xylinas E, Bouzouita A, Chebil M, Pfister C. Nouhaud FX, et al. Among authors: roumiguie m. Urol Oncol. 2021 Mar;39(3):195.e1-195.e6. doi: 10.1016/j.urolonc.2020.09.006. Epub 2020 Nov 16. Urol Oncol. 2021. PMID: 33214030
Re: Ming Yuen Teo, Jose Mauricio Mota, Karissa A. Whiting, et al. Fibroblast Growth Factor Receptor 3 Alteration Status is Associated with Differential Sensitivity to Platinum-based Chemotherapy in Locally Advanced and Metastatic Urothelial Carcinoma. Eur Urol 2020;78:907-15: Linking FGFR3 Mutation Status and Luminal Papillary Subtype to Response to Cisplatin-based Chemotherapy in Bladder Cancer.
Roumiguie M, Contreras-Sanz A, Black PC. Roumiguie M, et al. Eur Urol. 2021 Jun;79(6):e182-e183. doi: 10.1016/j.eururo.2021.03.028. Epub 2021 Apr 8. Eur Urol. 2021. PMID: 33838962 No abstract available.
Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study.
Balar AV, Kamat AM, Kulkarni GS, Uchio EM, Boormans JL, Roumiguié M, Krieger LEM, Singer EA, Bajorin DF, Grivas P, Seo HK, Nishiyama H, Konety BR, Li H, Nam K, Kapadia E, Frenkl T, de Wit R. Balar AV, et al. Among authors: roumiguie m. Lancet Oncol. 2021 Jul;22(7):919-930. doi: 10.1016/S1470-2045(21)00147-9. Epub 2021 May 26. Lancet Oncol. 2021. PMID: 34051177 Clinical Trial.
Managing Discordant Findings Between Multiparametric Magnetic Resonance Imaging and Transrectal Magnetic Resonance Imaging-directed Prostate Biopsy-The Key Role of Magnetic Resonance Imaging-directed Transperineal Biopsy.
Bajeot AS, Covin B, Meyrignac O, Pericart S, Aziza R, Portalez D, Graff-Cailleaud P, Ploussard G, Roumiguié M, Malavaud B. Bajeot AS, et al. Among authors: roumiguie m. Eur Urol Oncol. 2022 Jun;5(3):296-303. doi: 10.1016/j.euo.2021.06.001. Epub 2021 Jun 19. Eur Urol Oncol. 2022. PMID: 34154979
253 results